Pages

Thursday, November 4, 2010

OGX-011, A Potentially New Drug for Hormone Refractory Prostate Cancer

Currently, when men progress on hormone therapy, chemotherapy with Taxotere is the best option available but the average improvement in survival was not large. A new drug was recently tested in combination with Taxotere. Find out the results and implications of this study.

Related : Wireless baby monitor Discount camera telephoto lens

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.